Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5395-5404
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Figure 3 Changes of alpha-fetoprotein levels in patients 1-6 before and after treament.
A: AFP levels of patients 1 and 2; B: AFP levels of patients 3 and 4; C: AFP levels of patients 5 and 6. AFP: Alpha-fetoprotein.
- Citation: Shen J, Wang LF, Zou ZY, Kong WW, Yan J, Meng FY, Chen FJ, Du J, Shao J, Xu QP, Ren HZ, Li RT, Wei J, Qian XP, Liu BR. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(29): 5395-5404
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5395